- Home
- ORMP vs PMVP Comparison
ORMP vs PMVP Comparison
Compare ORMP & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- PMVP
- Stock Information
- Founded
- ORMP 2002
- PMVP 2013
- Country
- ORMP United States
- PMVP United States
- Employees
- ORMP N/A
- PMVP N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- ORMP Health Care
- PMVP Health Care
- Exchange
- ORMP Nasdaq
- PMVP Nasdaq
- Market Cap
- ORMP 90.2M
- PMVP 77.4M
- IPO Year
- ORMP N/A
- PMVP 2020
- Fundamental
- Price
- ORMP $2.32
- PMVP $1.14
- Analyst Decision
- ORMP Hold
- PMVP Strong Buy
- Analyst Count
- ORMP 1
- PMVP 1
- Target Price
- ORMP N/A
- PMVP $5.00
- AVG Volume (30 Days)
- ORMP 96.9K
- PMVP 2.6M
- Earning Date
- ORMP 11-06-2025
- PMVP 11-06-2025
- Dividend Yield
- ORMP N/A
- PMVP N/A
- EPS Growth
- ORMP N/A
- PMVP N/A
- EPS
- ORMP N/A
- PMVP N/A
- Revenue
- ORMP $2,000,000.00
- PMVP N/A
- Revenue This Year
- ORMP N/A
- PMVP N/A
- Revenue Next Year
- ORMP N/A
- PMVP N/A
- P/E Ratio
- ORMP N/A
- PMVP N/A
- Revenue Growth
- ORMP N/A
- PMVP N/A
- 52 Week Low
- ORMP $1.82
- PMVP $0.81
- 52 Week High
- ORMP $3.09
- PMVP $1.84
- Technical
- Relative Strength Index (RSI)
- ORMP 59.64
- PMVP 36.32
- Support Level
- ORMP $2.17
- PMVP $1.19
- Resistance Level
- ORMP $2.45
- PMVP $1.40
- Average True Range (ATR)
- ORMP 0.07
- PMVP 0.16
- MACD
- ORMP 0.02
- PMVP -0.04
- Stochastic Oscillator
- ORMP 61.76
- PMVP 1.41
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.